express
on 12 Sep 2023
Last Applicant/ Owned by
6 Wiryeseong-daero, Songpa-gu
Seoul
KR
05544
Serial Number
97492050 filed on 07th Jul 2022
Registration Number
N/A
Correspondent Address
CHARLES G. ZUG
NELSON MULLINS RILEY & SCARBOROUGH LLP
301 SOUTH COLLEGE STREET
SUITE 2300, IP DEPARTMENT
CHARLOTTE, NC 28202
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Software design and development; image processing software design; computer programming in the medical field; development of computer software for use with medical equipment; providing computer software technical support services, namely, troubleshooting of computer software problems, in the field of medical diagnostics; development of medical devices, namely, product development in the field of mRead More
Software design and development; image processing software design; computer programming in the medical field; development of computer software for use with medical equipment; providing computer software technical support services, namely, troubleshooting of computer software problems, in the field of medical diagnostics; development of medical devices, namely, product development in the field of medical devices; providing technical support services, namely, troubleshooting in the nature of diagnosing problems with medical diagnostic instruments; product design and development in the field of software; design of new products for others; new product design services; technology research in the field of data processing; development of data processing programs by order of third parties; design of data processing programs for computers; providing online non-downloadable software for use in the field of clinical trials for online medical monitoring and case review, for video conferencing and online meetings, for sharing and viewing medical and clinical data and information; development of computer software for data processing
No 97492050
No Service Mark
No 074787.09000
No
No
No
No
No
No
No
No
10.09.01 -
Medicines and nonmedical products in tablet, capsule or powder form; suppositories
26.01.15 -
Three circles
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.11.03 -
Incomplete rectangles
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
The mark consists of the wording "OncoTrial Board" in stylized font, beneath the stylized design of a pill divided in two halves with three unconnected dots and five dots connected by lines all below and within an open rectangular line with curved corners.
| Status Date | Action Taken |
|---|---|
| 12th Sep 2023 | ABANDONMENT - EXPRESS MAILED |
| 12th Sep 2023 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |
| 16th Aug 2023 | TEAS EXPRESS ABANDONMENT RECEIVED |
| 17th May 2023 | NON-FINAL ACTION WRITTEN |
| 17th May 2023 | NON-FINAL ACTION E-MAILED |
| 17th May 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 21st Apr 2023 | ASSIGNED TO EXAMINER |
| 05th Oct 2022 | LETTER OF PROTEST EVIDENCE FORWARDED |
| 18th Aug 2022 | ASSIGNED TO LIE |
| 18th Aug 2022 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
